MedPath

Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy

Phase 2
Completed
Conditions
Comparing of 2 Different Volumes in ESPB in Patients Undergoing MRM
Interventions
Drug: Group 2(high concentration-low volumecbupivacaine US guided Erector Spinae Plane block)
Registration Number
NCT05813158
Lead Sponsor
Cairo University
Brief Summary

The aim of this study is to compare and evaluate the analgesic effects of ultrasound-guided Erector Spinae Plane block using low volumes and high concentrations versus high volumes and low concentrations in patients undergoing MRM.

Detailed Description

Multiple regional techniques have been developed in recent years for postoperative analgesia of breast surgery including ESPB aiming to be effective and associated with less complications when compared to the gold standard techniques (thoracic epidural analgesia or paravertebral block)..

Ultrasound guided erector spinae plane (ESPB) block was described in 2016 as a novel regional anesthetic technique for acute and chronic thoracic pain, it has been used as a regional anesthetic technique for breast surgery based on case reports and case series. It is a paraspinal fascial plane block that involves injection of local anesthetic deep in the erector spinae muscle and superficial to the tips of the thoracic transverse processes. The site of injection is distant from the pleura, major blood vessels, and spinal cord; hence, performing the ESPB has relatively few contraindications. The injected local anesthetic drug blocks the ventral and dorsal rami of spinal nerves on the paravertebral area .

Multiple studies have reported improved efficiency of interfascial blocks by increasing the volume of injection promoting better spread of local anesthesia. According to the authors best knowledge there is no studies comparing different volumes and concentration in ESPB in patients undergoing MRM This study aims to see the effect of fixing the drug mass of anaesthetic given in both groups, while altering the concentration of the anesthetic and total volume administered. One group will receive a lower concentration and higher volume, while the other will receive a higher concentration and lower volume.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
52
Inclusion Criteria

Age starting from 18 to 60 years.

  • Genders eligible for study: female sex.
  • ASA II-III.
  • Patients undergoing modified radical mastectomy.
  • Body mass index (BMI) from 18.5 to 30 kg/m2.
Exclusion Criteria

Patient refusal

  • Known allergy to local anesthetics
  • Bleeding disorders; platelets count <50,000, prothrombin concentration <60% or any coagulopathy disorder.
  • Use of any anti-coagulants
  • Inability to provide informed consent
  • ASA IV
  • Neurological disorders
  • Patient with psychiatric disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1Group 1(low concentration-high volume bupivacaine US guided Erector Spinae Plane block)Patients will preoperatively receive low concentration-high volume U/S ESP block, and then the patient will be transferred to the operating room one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline}, for each patient.
Group 2Group 2(high concentration-low volumecbupivacaine US guided Erector Spinae Plane block)Patients will preoperatively receive high concentration-low volume U/S ESP block block, and then the patient will be transferred to the operating room one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% }, for each patien).
Primary Outcome Measures
NameTimeMethod
Total dose of morphine needed postoperativelyThrough Study Completion Up to 1 Day

Total dose of morphine needed postoperatively

Secondary Outcome Measures
NameTimeMethod
Time to first rescue analgesia, starting after extubationThrough Study Completion over the first 24 hours postoperative

Time to first rescue analgesia, starting after extubation

Duration of surgeryThrough Study Completion 24 hours postoperative

Duration of surgery

Blood loss,Through Study Completion,an average of 1day

Blood loss,

Total dose of fentanyl required intraoperative (including induction dose)Through study completion,an average of 1day

Total dose of fentanyl required intraoperative (including induction dose)

Pain score at 15, 30, 45 and 60 min., 3,6,12 and 24 h after surgerythrough study completion,an average of 1day

Pain score at 15, 30, 45 and 60 min., 3,6,12 and 24 h after surgery

Need for blood transfusionThrough Study Completion over the first 24 hours postoperative

Need for blood transfusion

Trial Locations

Locations (1)

Ahmed Abdalla Mohamed

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath